Congress trades and big insider sales, sent the day they're filed. Free.
Open in TelegramSVP, Clinical DevelopmentCIK 0002114309
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 22 | Xu Cong ClaireEVP, Clinical Development |  NBPNovaBridge BiosciencesOpen-market sale | SELL | $2,593 3,282 sh | Sep 1, 2026 traded Aug 31, 2026 | |
Xu Cong ClaireEVP, Clinical Development |
| NBPNovaBridge Biosciences Option exercise |
| M |
| — 4,079 sh |
| Sep 1, 2026 traded Aug 30, 2026 |
| 5 | Xu Cong ClaireEVP, Clinical Development | NBPNovaBridge Biosciences Option exercise | M | — 9,382 sh | Sep 1, 2026 traded Aug 30, 2026 |
| 5 | Xu Cong ClaireSVP, Clinical Development | NBPNovaBridge Biosciences Option exercise | M | — 5,405 sh | Jul 7, 2026 traded Jul 4, 2026 |
| 17 | Xu Cong ClaireSVP, Clinical Development | NBPNovaBridge Biosciences Open-market sale | SELL | $3,992 4,485 sh | Jul 7, 2026 traded Jul 6, 2026 |
| 5 | Xu Cong ClaireSVP, Clinical Development | NBPNovaBridge Biosciences Option exercise | M | — 12.4K sh | Jul 7, 2026 traded Jul 4, 2026 |
| 13 | Xu Cong ClaireSVP, Clinical Development | NBPNovaBridge Biosciences Option exercise | M | — 4,079 sh | Jun 2, 2026 traded May 30, 2026 |
| 21 | Xu Cong ClaireSVP, Clinical Development | NBPNovaBridge Biosciences Open-market sale | SELL | $14K 3,494 sh | Jun 2, 2026 traded Jun 1, 2026 |
| 9 | Xu Cong ClaireSVP, Clinical Development | NBPNovaBridge Biosciences Option exercise | M | — 9,382 sh | Jun 2, 2026 traded May 30, 2026 |